Colonoscopy is a type of screening test which is used for detection of colorectal cancer. It is dependent on pre procedure which is called as colonoscopy bowel preparation in this cleansing of colon is done in the patient’s colonoscopy. Colonoscopy bowel preparation drugs are classified into various types such as Isomotic Agents, Hypersosmotic Agents, Hyposmotic Agents, and Combination Agent.
Increase in research and development activities is the key driving factor which is expected to propel the global colonoscopy bowel preparation drugs market growth. For instance, in December 2019, ColonaryConcepts had announced the Phase III clinical trial of its Edible Colonoscopy preparation for bowel cleansing. Furthermore, adoption of collaboration activities by key players will positively influence the market growth. For instance, in KOREA PHARMA CO., LTD and Norgine B.V entered into exclusive license and distribution agreement in Korea for the commercialization and distribution of Norgine’s Product PLENVU. Moreover, rise in prevalence of colorectal cancer is expected to fuel the market growth during this analysis period.
However, occurrence of side effects like abdominal pain, abdominal swelling, nausea and vomiting are the challenging factors which are expected to hinder the global colonoscopy bowel preparation market growth
Global Colonoscopy Bowel Preparation Drugs Market is segmented into drug type such as Isomotic Agents (High-volume Polyethylene Glycol Preparations, Sulfate-free PEG-ELS, Low-volume PEG Preparations), Hypersosmotic Agents (Oral sodium Sulfate, Magnesium Citrate, Sodium Phosphate), Hyposmotic Agents, and Combination Agent. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, and Others.
Also, Global Colonoscopy Bowel Preparation Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Bayer AG, ColonaryConcepts, Bausch Health Companies Inc, Ferring B.V, Norgine B.V. KOREA PHARMA CO., LTD, and Others
By Drug Type Isomotic Agents High-volume Polyethylene Glycol Preparations Sulfate-free PEG-ELS Low-volume PEG Preparations Hypersosmotic Agents Oral sodium Sulfate Magnesium Citrate Sodium Phosphate Hyposmotic Agents Combination Agent
By Distribution Channel Hospital Pharmacies Retail Pharmacies Others
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Colonoscopy Bowel Preparation Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Colonoscopy Bowel Preparation Drugs Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
5.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Type
5.3.1 Isomotic Agents
5.3.1.1. High-Volume Polyethylene Glycol Preparations
5.3.1.2. Sulfate-free-PEG-ELS
5.3.1.3. Low Volume PEG preparations
5.3.2 Hypersosmotic Agents
5.3.2.1. Oral Sodium Sulfate
5.3.2.2. Magnesium Citrate
5.3.2.3. Sodium Phosphate
5.3.3. Hyposmotic Agents
5.3.4. Combination Agents
6 Global Colonoscopy Bowel Preparation Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Application
6.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Others
7Global Colonoscopy Bowel Preparation Drugs Market, By Region
7.1 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Region
7.2 Global Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Region
7.3 Global Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Region
8North America Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2019 – 2030)
8.1 Introduction
8.2 North America Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
8.3 North America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
8.4 North America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9Europe Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2019 – 2030)
9.1 Introduction
9.2 Europe Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
9.3 Europe Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
9.4 Europe Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2019 – 2030)
10.1 Introduction
10.2 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
10.3 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
10.4 Asia Pacific Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2019 – 2030)
11.1 Introduction
11.2 Latin America Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
11.3 Latin America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
11.4 Latin America Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
12Middle East Colonoscopy Bowel Preparation Drugs Market Analysis and Forecast (2019 – 2030)
12.1 Introduction
12.2 Middle East Colonoscopy Bowel Preparation Drugs Market Share Analysis, By Type
12.3 Middle East Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Application
12.4 Middle East Colonoscopy Bowel Preparation Drugs Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Bayer AG
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 ColonaryConcepts
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Bausch Health Companies Inc
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Ferring B.V
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Norgine B.V
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 KOREA PHARMA CO., LTD
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Others
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
